
Pharmaceuticals Healthcare & Cosmetics Overview
DAFSA's experts in the pharmaceutical-healthcare-cosmetic sector can help you understand and quantify your specific customer markets by addressing marketing, economic, and regulatory issues. We can provide you with customized or subscription-based services to meet your specified requirements.
DAFSA has over 20 years of experience in the healthcare field and has a bilingual staff of 15 dedicated analysts located in our Paris and London offices. Our databases are kept current through our network of contacts and dedicated survey-takers. Our quality of service has been certified by AFNOR.
DAFSA experts work closely with Global Insight, our parent company, and its specialized analysts in the pharmaceutical-healthcare-cosmetic sector to fulfill your needs.
- International, domestic, and regional healthcare environment
- Price and reimbursement for pharmaceutical specialties
- Analyses of therapeutic classes
- Hospitals and nursing homes
- Hospital procurement and retrocessions.
- Health insurance and health services
- Direct store pharmacy sales
- Generics
- Prescription conditions and practitioners' spheres of influence
- Sales and marketing organization
- Wholesale and retail distribution logistics
- Cosmetics: beauty products distribution, networks, and positioning
- Pharmaceutical laboratories
- Medical-surgical equipment companies and medical devices companies
- Home services providers
- Wholesale distributors and storage companies
- Mutuelles 45
- Cosmetics manufacturers
- Para-pharmaceutical and diet brand names
- Public at large – patients
- Prescribing physicians – general practitioners – specialists – coordinators
- Store and hospital pharmacists
- Institutions – national – regional
- Nursing home and institutional directors
- Medical detailers
- Medications distributed to hospitals and in towns
- Prescription medications in areas of infectology, cardiology, hematology, and neurology
- Generics – OTC – Ethics
- Medical equipment
- Therapeutic nutrition
- Cosmetics
- Parapharmaceuticals
|